Spironolactone and Ventricular internal diameter abnormal - a phase IV clinical study of FDA data

Summary:

Ventricular internal diameter abnormal is reported as a side effect among people who take Spironolactone (spironolactone), especially for people who are male, 50-59 old, also take Furosemide, and have Cardiac failure.

The phase IV clinical study analyzes which people have Ventricular internal diameter abnormal when taking Spironolactone. It is created by eHealthMe based on reports of 119,147 people who have side effects when taking Spironolactone from the FDA, and is updated regularly.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Ventricular internal diameter abnormal?

Ventricular internal diameter abnormal is found to be associated with 18 drugs and 39 conditions by eHealthMe. Check the latest studies of Ventricular internal diameter abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

119,147 people reported to have side effects when taking Spironolactone.
Among them, 28 people (0.02%) have Ventricular internal diameter abnormal.

Could Spironolactone cause Ventricular internal diameter abnormal?

Among these 28 people:

What is the gender of people who have Ventricular internal diameter abnormal when taking Spironolactone? *

female: 10.71 %
male: 89.29 %

What is the age of people who have Ventricular internal diameter abnormal when taking Spironolactone? *

What are other drugs people take besides Spironolactone? *

What are other side effects people have besides Ventricular internal diameter abnormal? *

Ejection Fraction Decreased (systolic heart failure): 25 people, 89.29%
Mitral Valve Incompetence (inefficient heart valve): 17 people, 60.71%
Tricuspid Valve Incompetence (inefficient heart valve): 17 people, 60.71%
N-Terminal Prohormone Brain Natriuretic Peptide Increased: 15 people, 53.57%
Dyspnea (difficult or laboured breathing): 13 people, 46.43%
Enlarged Heart: 12 people, 42.86%
Oedema Peripheral (superficial swelling): 11 people, 39.29%
Ventricular Hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do): 10 people, 35.71%
Cardiac Failure Chronic: 10 people, 35.71%
Atrial Tachycardia (rhythm disturbance that arises in the atria): 9 people, 32.14%

What are the existing conditions these people have? *

Cardiac Failure: 5 people, 17.86%
Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 10.71%
Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 2 people, 7.14%
Diabetes: 2 people, 7.14%
Cardiac Failure Congestive: 2 people, 7.14%
Cardiac Failure Chronic: 2 people, 7.14%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 7.14%
Stable Angina (a constant chest pain): 1 person, 3.57%
Iron Deficiency Anaemia: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and have Ventricular internal diameter abnormal?

- Check whether Ventricular internal diameter abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Spironolactone:

Spironolactone (122,947 reports)

Ventricular internal diameter abnormal treatments and more:

Ventricular internal diameter abnormal (106 reports)

How severe was Ventricular internal diameter abnormal and when was it recovered:

Ventricular internal diameter abnormal in Spironolactone

Expand to all the drugs that have ingredients of spironolactone:

Ventricular internal diameter abnormal and drugs with ingredients of spironolactone (29 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular internal diameter abnormal:

Ventricular internal diameter abnormal (18 drugs)

Browse all the conditions that are associated with Ventricular internal diameter abnormal:

Ventricular internal diameter abnormal (39 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone (the active ingredients of Spironolactone) and Spironolactone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.